Emergent BioSolutions(美国)
Emergent BioSolutions
美国EmergentBioSolutionswww.emergentbiosolutions.comEmergentBioSolutions公司是一家生物制药企业,致力于免疫相关生物产品的开发、生产和商业化,其产品包括疫苗和疗法,能帮助人体免疫系统预防或治疗疾病。Emergent的上市产品BioThrax®(炭疽吸附疫苗)是美国食品药品管理局(FDA)认可的预防炭疽感染的疫苗。Emerge
nt公司准备启动和已经启动的开发项目中还有侧重于炭疽、肉毒中毒、伤寒、结核、乙肝和衣原体的一些计划。EmergentBioSolutionsInc.isaleadingbiopharmaceuticalcompanydedicatedtoonesimplemission—toprotectlife.Wedevelop,manufactureandcommercializeimmunerelatedbiologics,vaccinesandbiotherapeuticsthatassistthebody’simmunesystemtopreventortreatinfectiousandotherlifethreateningdiseases.Ourmarketedproduct,BioThrax®(AnthraxVaccineAdsorbed),istheonlyvaccinelicensedbytheU.S.FoodandDrugAdministrationforthepreventionofanthraxinfection.Ourproductpipelinealsoincludes:two“nextgeneration”anthraxvaccines,twoanthraxtherapeutics(immunoglobulinandmonoclonal),twobotulinumvaccinesandabotulinumtherapeutic,anoraltyphoi